Fractyl Research Development from 2010 to 2026
| GUTS Stock | 0.39 0.03 6.98% |
Research Development | First Reported 2020-03-31 | Previous Quarter 21.2 M | Current Value 17.5 M | Quarterly Volatility 5.4 M |
Check Fractyl Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fractyl Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 500.5 K, Interest Expense of 1.3 M or Selling General Administrative of 14.1 M, as well as many indicators such as Price To Sales Ratio of 1.1 K, Dividend Yield of 0.0 or PTB Ratio of 5.97. Fractyl financial statements analysis is a perfect complement when working with Fractyl Health Valuation or Volatility modules.
Fractyl | Research Development | Build AI portfolio with Fractyl Stock |
The evolution of Research Development for Fractyl Health Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Fractyl Health compares to historical norms and industry peers.
Latest Fractyl Health's Research Development Growth Pattern
Below is the plot of the Research Development of Fractyl Health Common over the last few years. It is Fractyl Health's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fractyl Health's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Fractyl Research Development Regression Statistics
| Arithmetic Mean | 36,253,081 | |
| Geometric Mean | 30,787,640 | |
| Coefficient Of Variation | 65.97 | |
| Mean Deviation | 19,276,468 | |
| Median | 20,885,000 | |
| Standard Deviation | 23,917,750 | |
| Sample Variance | 572.1T | |
| Range | 64.2M | |
| R-Value | 0.83 | |
| Mean Square Error | 190.9T | |
| R-Squared | 0.69 | |
| Significance | 0.000039 | |
| Slope | 3,926,175 | |
| Total Sum of Squares | 9152.9T |
Fractyl Research Development History
About Fractyl Health Financial Statements
Fractyl Health shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although Fractyl Health investors may analyze each financial statement separately, they are all interrelated. The changes in Fractyl Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fractyl Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 81 M | 85.1 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fractyl Stock Analysis
When running Fractyl Health's price analysis, check to measure Fractyl Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fractyl Health is operating at the current time. Most of Fractyl Health's value examination focuses on studying past and present price action to predict the probability of Fractyl Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fractyl Health's price. Additionally, you may evaluate how the addition of Fractyl Health to your portfolios can decrease your overall portfolio volatility.